Patient data can be processed to form retrospective and prospective conclusions. HealthMaker David Parke, II, MD, CEO of the American Academy of Ophthalmology talks in this video about how "big data" stands to impact ophthalmology research.
The power of the data instead of having a 100 patients in the trial, you may now have 20, 000, now allows you to do very, very powerful and statistically significant. If you were a retrospective data, or even prospected data, because these patients are entered into the registry, kind of a lot edge literally as they come in.
David Parke, II, MD, CEO of the American Academy of Ophthalmology, discusses the link between diabetes and vision problems, the quest for a cure for blindness, and how the eyes are a window to your overall health.
See All HealthMakers